English
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

tricuspid atresia/prostaglandin

The link is saved to the clipboard
ArticlesClinical trialsPatents
Page 1 from 16 results

Management of tricuspid atresia with orally administered prostaglandin E2.

Only registered users can translate articles
Log In/Sign up

[Infusion of prostaglandin E1 in ductus-dependent congenital heart diseases. Analysis of 47 cases].

Only registered users can translate articles
Log In/Sign up
Prostaglandin E1, used since 1975, has changed favorably the clinical and surgical prognosis of neonates with congenital heart defects, mainly those with a variety of ductus-dependent defects. Due to recent modifications that have been observed with this drug as far as dosage, side effects, duration

Prostaglandin E1 in infants with congenital heart disease: Indian experience.

Only registered users can translate articles
Log In/Sign up
BACKGROUND E-type prostaglandins (PGE1) can effectively maintain the patency of the ductus arteriosus in neonates. Its use, therefore and be life saving in infants born with ductus dependent congenital heart disease. Although PGE1 is available for over two decade in western world, it has been

[Functional tricuspid atresia in a newborn infant with cardiac rhabdomyoma].

Only registered users can translate articles
Log In/Sign up
Cardiac rhabdomyomas are benign tumours closely associated with tuberous sclerosis. We report on a neonate with a cardiac rhabdomyoma, which simulated tricuspid atresia with duct-depending pulmonary perfusion due to almost complete obliteration of right ventricular cavum. Under infusion of

[Prostaglandins E1 in the treatment of neonatal cardiopathies related to ductus arteriosus. 19 cases].

Only registered users can translate articles
Log In/Sign up
A series of 19 neonates with persistent ductus arteriosus associated with right heart pathology such as pulmonary or tricuspid atresia (13 cases), left heart and aortic arch pathology (3 cases) and simple transposition of the great arteries (3 cases) is presented. The efficacity of an infusion of

Long-term prostaglandin E1 therapy in congenital heart defects.

Only registered users can translate articles
Log In/Sign up
Seventeen neonates received an intravenous infusion of prostaglandin E1 for an average of 39 days (range 8 to 104). Seven (group 1) had transposition of the great arteries with no ventricular septal defect or a small one; eight (group 2) had ductus-dependent pulmonary flow (pulmonary atresia or

[Prostaglandin E2 in newborns with congenital heart disease].

Only registered users can translate articles
Log In/Sign up
Prostaglandins of the E-type are potent ductus dilatators not only in vitro but also in vivo, as could be shown in the former literature. We report on 20 newborn children, in whom we only used prostaglandin E2 to perform a better lung or kidney perfusion by opening the ductus arteriosus. The

Case histories of neonates with congenital heart disease.

Only registered users can translate articles
Log In/Sign up
The rate of extracardiac malformation (ECM) associated with congenital heart disease (CHD) is high in neonates. 108 cases of 212 neonates with CHD had ECM (50.9%). Main ECMs were digestive system anomalies (36.1%), chromosomal aberrations (26.8%), respiratory system anomalies (21.3%), CNS anomalies

Bilateral pulmonary artery banding for resuscitation in high-risk, single-ventricle neonates and infants: a single-center experience.

Only registered users can translate articles
Log In/Sign up
OBJECTIVE Bilateral pulmonary artery banding with or without ductal stenting has been performed as a resuscitative intervention for patients considered at too high risk for conventional single ventricle palliation. The purpose of the present study was to determine the outcomes using this

Management of Ebstein's anomaly and pure tricuspid insufficiency in the neonate.

Only registered users can translate articles
Log In/Sign up
Because the pulmonary vascular resistance is very elevated at birth, severe tricuspid regurgitation is poorly tolerated and even life-threatening in the newborn. The etiology may be tricuspid valve papillary muscle rupture or the more ominous Ebstein's anomaly, with its associated dysfunctional

[Interruption of the aortic arch and malformative cardiac lesions requiring repair under extracorporeal circulation. Apropos of 3 cases].

Only registered users can translate articles
Log In/Sign up
Interruption of the aortic arch is practically always associated with intracardiac malformations of variable complexity, at the least, a ventricular septal defect. Surgery is usually performed in two stages: aortic repair and pulmonary artery banding after intravenous prostaglandin administration.

Preoperative ECMO in congenital cyanotic heart disease using the AREC system.

Only registered users can translate articles
Log In/Sign up
BACKGROUND In cyanotic congenital heart disease, oxygen delivery is impaired either by reduced pulmonary perfusion or by limited entry of oxygenated blood into the systemic circulation. Additional impairment of oxygen delivery (eg, in pulmonary hypertension) leads to hypoxic cerebral damage.

Management of Congenital Heart Disease: State of the Art-Part II-Cyanotic Heart Defects.

Only registered users can translate articles
Log In/Sign up
In this review management of the most common cyanotic congenital heart defects (CHDs) was discussed; the management of acyanotic CHD was reviewed in Part I of this series. While the need for intervention in acyanotic CHD is by and large determined by the severity of the lesion, most cyanotic CHDs

Operative outcome and intermediate term follow-up of neonatal Blalock-Taussig shunts.

Only registered users can translate articles
Log In/Sign up
BACKGROUND The neonatal age group is considered to be one of the important risk factors for perioperative morbidity and mortality as well as poor long-term patency following Blalock-Taussig shunts. RESULTS Out of a total of 190 patients who underwent Blalock-Taussig shunts in our institute between

Formalin infiltration of ductus arteriosus in cyanotic congenital heart disease.

Only registered users can translate articles
Log In/Sign up
Formalin infiltration of the ductus arteriosus was performed in 13 neonates with pulmonary atresia (three with ventricular septal defect, two with tricuspid atresia, and eight with intact ventricular septum, one of whom had Ebstein's anomaly) in an attempt to maintain duct patency. Nine patients had
Join our facebook page

The most complete medicinal herbs database backed by science

  • Works in 55 languages
  • Herbal cures backed by science
  • Herbs recognition by image
  • Interactive GPS map - tag herbs on location (coming soon)
  • Read scientific publications related to your search
  • Search medicinal herbs by their effects
  • Organize your interests and stay up do date with the news research, clinical trials and patents

Type a symptom or a disease and read about herbs that might help, type a herb and see diseases and symptoms it is used against.
*All information is based on published scientific research

Google Play badgeApp Store badge